126 related articles for article (PubMed ID: 38337174)
1. Oculocutaneous albinism type 4: Novel compound heterozygous mutations in the SLC45A2 gene in a Chinese case.
He D; Liu X; Yao T; Hu J; Zheng X; Tang L; Fan X
Mol Genet Genomic Med; 2024 Feb; 12(2):e2385. PubMed ID: 38337174
[TBL] [Abstract][Full Text] [Related]
2. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
[TBL] [Abstract][Full Text] [Related]
3. SLC45A2 variations in Indian oculocutaneous albinism patients.
Sengupta M; Chaki M; Arti N; Ray K
Mol Vis; 2007 Aug; 13():1406-11. PubMed ID: 17768386
[TBL] [Abstract][Full Text] [Related]
4. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
[TBL] [Abstract][Full Text] [Related]
5. Identification of two novel mutations in the SLC45A2 gene in a Hungarian pedigree affected by unusual OCA type 4.
Tóth L; Fábos B; Farkas K; Sulák A; Tripolszki K; Széll M; Nagy N
BMC Med Genet; 2017 Mar; 18(1):27. PubMed ID: 28298193
[TBL] [Abstract][Full Text] [Related]
6. A Japanese Family With Autosomal Dominant Oculocutaneous Albinism Type 4.
Oki R; Yamada K; Nakano S; Kimoto K; Yamamoto K; Kondo H; Kubota T
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1008-1016. PubMed ID: 28192564
[TBL] [Abstract][Full Text] [Related]
7. Oculocutaneous albinism type IV: A boy of Moroccan descent with a novel mutation in SLC45A2.
Konno T; Abe Y; Kawaguchi M; Storm K; Biervliet M; Courtens W; Kono M; Tomita Y; Suzuki T
Am J Med Genet A; 2009 Aug; 149A(8):1773-6. PubMed ID: 19610114
[TBL] [Abstract][Full Text] [Related]
8. Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism.
Jiang B; Zhang H; Kan Y; Gao X; Du Z; Liu Q
Mol Genet Genomic Med; 2024 Jan; 12(1):e2297. PubMed ID: 37882226
[TBL] [Abstract][Full Text] [Related]
9. Mutational Analysis of TYR, OCA2, SLC45A2, and TYRP1 Genes Identifies Novel and Reported Mutations in Chinese Families with Oculocutaneous Albinism.
Xu B; Chen X; Li H
Altern Ther Health Med; 2023 Oct; 29(7):278-283. PubMed ID: 37471664
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing identifies a novel pathogenic variation [p.(Gly194valfs*7)] in SLC45A2 in the homozygous state in multiple members of a family with oculocutaneous albinism in southern India.
Lewis SS; Girisha KM
Clin Exp Dermatol; 2020 Jun; 45(4):409-413. PubMed ID: 31630438
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of a Chinese family with oculocutaneous albinism.
Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221
[TBL] [Abstract][Full Text] [Related]
12. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism.
Ko JM; Yang JA; Jeong SY; Kim HJ
Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196
[TBL] [Abstract][Full Text] [Related]
13. Mutational Analysis on Membrane Associated Transporter Protein (MATP) and Their Structural Consequences in Oculocutaeous Albinism Type 4 (OCA4)-A Molecular Dynamics Approach.
Kamaraj B; Purohit R
J Cell Biochem; 2016 Nov; 117(11):2608-19. PubMed ID: 27019209
[TBL] [Abstract][Full Text] [Related]
14. Identification of Five Novel Variants in Chinese Oculocutaneous Albinism by Targeted Next-Generation Sequencing.
Qiu B; Ma T; Peng C; Zheng X; Yang J
Genet Test Mol Biomarkers; 2018 Apr; 22(4):252-258. PubMed ID: 29437493
[TBL] [Abstract][Full Text] [Related]
15. A single base deletion in the SLC45A2 gene in a Bullmastiff with oculocutaneous albinism.
Caduff M; Bauer A; Jagannathan V; Leeb T
Anim Genet; 2017 Oct; 48(5):619-621. PubMed ID: 28737247
[TBL] [Abstract][Full Text] [Related]
16. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase.
Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J
Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744
[TBL] [Abstract][Full Text] [Related]
17. Two novel splicing mutations in the SLC45A2 gene cause Oculocutaneous Albinism Type IV by unmasking cryptic splice sites.
Straniero L; Rimoldi V; Soldà G; Mauri L; Manfredini E; Andreucci E; Bargiacchi S; Penco S; Gesu GP; Del Longo A; Piozzi E; Asselta R; Primignani P
J Hum Genet; 2015 Sep; 60(9):467-71. PubMed ID: 26016411
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of spectral distribution of a large cohort of Chinese patients with non-syndromic oculocutaneous albinism facilitates genetic diagnosis.
Zhong Z; Gu L; Zheng X; Ma N; Wu Z; Duan J; Zhang J; Chen J
Pigment Cell Melanoma Res; 2019 Sep; 32(5):672-686. PubMed ID: 31077556
[TBL] [Abstract][Full Text] [Related]
19. Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report.
Wang H; Wan Y; Yang Y; Li H; Mao L; Gao S; Xu J; Wang J
BMC Med Genet; 2019 Jul; 20(1):130. PubMed ID: 31345173
[TBL] [Abstract][Full Text] [Related]
20. Homozygosity mapping and whole-exome sequencing to detect SLC45A2 and G6PC3 mutations in a single patient with oculocutaneous albinism and neutropenia.
Cullinane AR; Vilboux T; O'Brien K; Curry JA; Maynard DM; Carlson-Donohoe H; Ciccone C; ; Markello TC; Gunay-Aygun M; Huizing M; Gahl WA
J Invest Dermatol; 2011 Oct; 131(10):2017-25. PubMed ID: 21677667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
